Literature DB >> 20643585

Human RECQL5 overcomes thymidine-induced replication stress.

Rachel Blundred1, Katie Myers, Thomas Helleday, Alastair S H Goldman, Helen E Bryant.   

Abstract

Accurate DNA replication is essential to genome integrity and is controlled by five human RecQ helicases, of which at least three prevent cancer and ageing. Here, we have studied the role of RECQL5, which is the least characterised of the five human RecQ helicases. We demonstrate that overexpressed RECQL5 promotes survival during thymidine-induced slowing of replication forks in human cells. The RECQL5 protein relocates specifically to stalled replication forks and suppresses thymidine-induced RPA foci, CHK1 signalling, homologous recombination and gammaH2AX activation. It is unlikely that RECQL5 promotes survival through translesion synthesis as PCNA ubiquitylation is also reduced. Interestingly, we also found that overexpressing RECQL5 relieves cells of the cell cycle arrest normally imposed by thymidine, but without causing mutations. In conclusion, we propose that RECQL5 stabilises the replication fork allowing replication to overcome the effects of thymidine and complete the cell cycle. Copyright (c) 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20643585     DOI: 10.1016/j.dnarep.2010.06.009

Source DB:  PubMed          Journal:  DNA Repair (Amst)        ISSN: 1568-7856


  10 in total

1.  Genome-wide comprehensive analysis of human helicases.

Authors:  Pavan Umate; Narendra Tuteja; Renu Tuteja
Journal:  Commun Integr Biol       Date:  2011-01

Review 2.  Human RECQL5: guarding the crossroads of DNA replication and transcription and providing backup capability.

Authors:  Venkateswarlu Popuri; Takashi Tadokoro; Deborah L Croteau; Vilhelm A Bohr
Journal:  Crit Rev Biochem Mol Biol       Date:  2013-04-29       Impact factor: 8.250

Review 3.  Helicase-inactivating mutations as a basis for dominant negative phenotypes.

Authors:  Yuliang Wu; Robert M Brosh
Journal:  Cell Cycle       Date:  2010-10-15       Impact factor: 4.534

4.  Clinicopathological and prognostic significance of RECQL5 helicase expression in breast cancers.

Authors:  Arvind Arora; Tarek M A Abdel-Fatah; Devika Agarwal; Rachel Doherty; Deborah L Croteau; Paul M Moseley; Khalid Hameed; Andrew Green; Mohammed A Aleskandarany; Emad A Rakha; Karl Patterson; Graham Ball; Stephen Y T Chan; Ian O Ellis; Vilhelm A Bohr; Helen E Bryant; Srinivasan Madhusudan
Journal:  Carcinogenesis       Date:  2015-11-19       Impact factor: 4.944

5.  RECQL5 cooperates with Topoisomerase II alpha in DNA decatenation and cell cycle progression.

Authors:  Mahesh Ramamoorthy; Takashi Tadokoro; Ivana Rybanska; Avik K Ghosh; Robert Wersto; Alfred May; Tomasz Kulikowicz; Peter Sykora; Deborah L Croteau; Vilhelm A Bohr
Journal:  Nucleic Acids Res       Date:  2011-10-19       Impact factor: 16.971

6.  Altered RECQL5 expression in urothelial bladder carcinoma increases cellular proliferation and makes RECQL5 helicase activity a novel target for chemotherapy.

Authors:  Karl Patterson; Lovleen Arya; Sarah Bottomley; Susan Morgan; Angela Cox; James Catto; Helen E Bryant
Journal:  Oncotarget       Date:  2016-11-15

7.  RECQL5 plays an essential role in maintaining genome stability and viability of triple-negative breast cancer cells.

Authors:  Jin Peng; Lichun Tang; Mengjiao Cai; Huan Chen; Jiemin Wong; Pumin Zhang
Journal:  Cancer Med       Date:  2019-06-23       Impact factor: 4.452

8.  Frame-shift mediated reduction of gain-of-function p53 R273H and deletion of the R273H C-terminus in breast cancer cells result in replication-stress sensitivity.

Authors:  Viola Ellison; George K Annor; Clara Freedman; Gu Xiao; Devon Lundine; Elzbieta Freulich; Carol Prives; Jill Bargonetti
Journal:  Oncotarget       Date:  2021-06-08

9.  Evaluating the Role of p38 MAPK in the Accelerated Cell Senescence of Werner Syndrome Fibroblasts.

Authors:  Terence Davis; Amy J C Brook; Michal J Rokicki; Mark C Bagley; David Kipling
Journal:  Pharmaceuticals (Basel)       Date:  2016-04-28

10.  Molecular-genetic profiling and high-throughput in vitro drug screening in NUT midline carcinoma-an aggressive and fatal disease.

Authors:  Anja Stirnweiss; Joyce Oommen; Rishi S Kotecha; Ursula R Kees; Alex H Beesley
Journal:  Oncotarget       Date:  2017-12-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.